Global Internal Fixation & Sealants Market Size & Trends Report Segmented by Product (Internal Fixation Products, Sealants), Application (Hernia Repair, Gastrointestinal Surgeries, Cardiovascular Surgeries), End-user Analysis & Regional Forecast to 2031

Internal fixation products are used for tissue support and mesh fixation, with hernia surgeries being the major application. Sealants are used to prevent leaks of fluids internally in gastrointestinal surgeries, thoracic surgeries or cardiovascular surgeries among others. Internal fixation market includes mechanical (tacks) and adhesive based systems. Internal fixation products and sealants work synergistically to improve surgical performance in both adult and pediatric populations, resulting in a reduction in postoperative complications.

Growing adoption in MIS and high-risk procedures to propel market demand

The increased use of minimally invasive surgery (MIS) as well as higher risk procedures, is positively impacting the demand for internal fixation products and surgical sealants. MIS share of inpatient surgery volumes and that of robot-assisted procedures has increased significantly over the past decade. MIS techniques are gaining acceptance due to less trauma to the patient during the intervention, reduced hospital duration, and faster recovery times compared to open procedures. In hernia repairs, laparoscopic methods require dependable internal fixation devices to adhere the meshes to the intra-abdominal structure. Mechanical tacks and adhesive fixation devices allow for targeted fixation that is secure and involves lower level of intervention which is consistent with the principles of MIS. Similarly, surgical sealants are emerging as complemental adjuncts to minimize complications such as fluid leaks, which improve surgical outcomes.

High-risk procedures, such as gastrointestinal, thoracic and cardiovascular surgeries, also provide opportunities for market growth of fixation devices and surgical sealants. In gastrointestinal surgeries, surgical sealants assist in preventing anastomotic leaks that can result in some of the most serious post-operative complications. In thoracic and cardiovascular procedures, when risk is even greater, surgical sealants play an important role in managing bleeding and controlling fluid transfer across delicate tissues. For internal fixation, high-risk hernia repairs like ventral or incisional hernias, require robust fixation solutions with expanded regulatory claims that justify higher-priced variants. For example, fixation products designed for complex abdominal wall reconstructions often combine mechanical and adhesive approaches to ensure greater stability and reduce recurrence rates.

As the surgical environment evolves, there is an increasing emphasis on innovation in MIS and high-risk procedures that is driving manufacturers to develop new premium priced products in internal fixation and sealants space. Companies are investing in bioabsorbable fixation systems and next generation sealants that complement and even adapt to how tissue will perform and eventually break down to minimize long-term complications. For instance, bioabsorbable tacks that dissolve over time help minimize chronic pain problems associated with permanent implants. Similarly, advanced sealants with improved biocompatibility will continue to expand indications beyond cardiac and GI traditional uses. The drive towards more minimally invasive and complex high-risk procedures therefore will increase market growth as well as provide differentiation and premium pricing opportunity in both internal fixation and sealants, which will encourage both to become more supported in surgical practice.

To learn more about this report, download the PDF brochure

Technological advancements in internal fixation & sealants driving the market growth

New technologies for internal fixation and sealants are driving growth in the market by increasing surgical precision, safety, and outcomes. In internal fixation for surgical procedures, developments like bioabsorbable tacks and adhesive-based systems decreases complications over the longer term, such as chronic pain, in addition to allowing for minimally-invasive uses. Similarly, next-generation sealants with better biocompatibility, improved adhesion, and quicker setting times are driving their use in gastrointestinal, thoracic, as well as cardiovascular surgical procedures.

Some of the technological advancements are listed below-

• In November 2023, H.B. Fuller launched Swiftmelt 1515-I, its first bio-compatible adhesive for medical tape applications, designed to deliver secure stick-to-skin performance under high temperatures and humidity in the IMEA region
• In May 2022, Advanced Medical Solutions Group plc received FDA 510(k) approval for LiquiBand XL, a wound closure device combining surgical mesh and glue for longer wounds

These new technologies improve efficiency in complex surgical procedures while allowing for the pricing of premium products and attract more users. As hospitals are concerned with more patient recovery and reduced complications due to hospital-acquired infection, in particular, advanced fixation and sealant technologies are likely to lead to sustained growth.

Growing acceptance of internal fixation and sealants fuels the growth of the market

The increasing acceptance of internal fixation products and surgical sealants is becoming a significant factor in market growth, as hospitals and surgeons are recognizing their capacity to improve surgical efficiency and patient outcomes. In the US, hospital settings and surgeons showcase evident openness to utilize new adhesives and sealants in surgical procedures, even if at a higher price point. Surgeons are valuing closure techniques that promote efficiencies, reduce complications, and shorten patient recovery time. The trend is aided by a newer generation of surgeons receiving education early on the use of these products in surgery, aiding the transition away from traditional suturing methods. As a result, the US market is establishing markers for adoption and innovation in fixation and closure technology.

The European market is generally more conservative with surgical techniques than the US, but there is a greater willingness among younger surgeons to adopt adhesives and sealants in surgical procedures, which bodes well for market development, albeit likely slow and steady. In Europe, the market is still under-penetrated but signals a considerable growth opportunity. More than 80% of the hernia mesh fixation products continued to utilize mechanical tacks into the market. Although the glue-based fixation method is receiving more attention as it can mitigate the trauma associated with using tacks, provide safer fixation in sensitive anatomy, and reduce post-operative pain.

Furthermore, the clinical advantages of adhesives and sealants are also expanding the breadth of use well beyond hernia repairs and into gastrointestinal, thoracic, and cardiovascular surgeries. Their ability to reduce leaks, bleeding, and recurrence makes them valuable adjuncts or alternatives to traditional closure devices. In addition, innovative technologies like bioabsorbable and biocompatible adhesives are emerging from the industry that will align with the changing demands of surgery. Surgeons, both in developed and emerging markets, are increasingly amenable to using these high-tech products, demonstrating the transition to value-based care, in which improved clinical outcomes justifies the increase in cost for a product. This is increasing acceptance, driven by efficiency savings, generation acceptance, and clinical change is likely to continue to sustain the growth momentum of the internal fixation and sealants market.

To learn more about this report, download the PDF brochure

Product Segment Outlook

Sealants’ is the larger market segment and is used primarily in procedures like dural closure, thoracic and lung sealing, bowel sealing in various internal surgeries. Sealants serve a broader range of surgical applications like bleeding control and tissue sealing across multiple specialties, making their market larger. In contrast, internal adhesives are more specialized, mainly used for hernia mesh fixation and few other niche procedures, limiting their market size. However, internal fixation segment is expected to register a higher CAGR over the forecast period attributed to increasing demand in specialized areas like hernia mesh fixation and expanding use in niche surgeries (e.g., cosmetic and trauma), driven by technological advances and rising adoption.

Regional Outlook: North America expected to hold a major share in the internal fixation & sealants market

North America held largest share of the global market in 2025. The US is the largest and fastest-growing internal fixation and sealants market, stimulated by healthcare budget expansions, sophisticated surgical infrastructure, and rapid adoption of MIS. The US has a larger footprint of outpatient surgical centers, larger growing procedure volumes, and, surgeons in the US are much more likely to adopt new technologies at even higher price points. Europe is notable, but the penetration of adhesives and sealants is more conservative and slower. The APAC, LATAM and MEA markets are smaller, but overall, they have long-term potential as availability of healthcare expands.

Competitive Landscape Analysis

The global internal fixation & sealants market is marked by the presence of established and emerging market players such as Ethicon (Johnson & Johnson Surgical Technologies) (US); Medtronic plc (US); Advanced Medical Solutions Group plc (UK); Becton, Dickinson and Company (US); H.B. Fuller (US); B. Braun SE (Germany); TISSIUM (France); Integra LifeSciences Corporation (US); Healthium Medtech Limited (India); and Artivion, Inc (US); among others. Some of the key strategies adopted by market players include product innovation and development, strategic partnerships and collaborations, mergers and acquisitions, and geographic expansion.

To learn more about this report, download the PDF brochure

Report Scope

Global Internal Fixation & Sealants Market Segmentation

This report by Medi-Tech Insights provides the size of the global internal fixation & sealants market at the regional- and country-level from 2024 to 2031. The report further segments the market based on product, application, and end-user.

Market Size & Forecast (2024-2031), By Product, USD Billion

• Internal Fixation Products
• Sealants

Market Size & Forecast (2024-2031), By Application, USD Billion

• Hernia Repair
• Gastrointestinal (GI) Surgeries
• Cardiovascular Surgeries
• Other Applications

Market Size & Forecast (2024-2031), By End-user, USD Billion

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Other End Users

Market Size & Forecast (2024-2031), By Region, USD Billion

• North America
  • US
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East & Africa

Related Reports:

Global Medical Adhesive Tapes Market Size & Trends Report Segmented by Resin Type (Acrylic, Silicon, Rubber), Backing Material (Paper, Plastic, Fabric), Application (Surgery, Wound Dressing, Splint), Industry Analysis & Regional Forecast to 2030

Global Biosurgery Market Size and Trends Report Segmented by Product Type (Hemostatic Agents, Adhesion Barriers, Sealants), Application (Orthopedic Surgery, Cardiovascular Surgery, General Surgery) Analysis and Regional Forecast to 2030